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In October 1995, epidemic “hemorrhagic fever,” without jaundice or renal manifestations,
was reported in rural Nicaragua following heavy flooding; 2259 residents were evaluated for
nonmalarial febrile illnesses (cumulative incidence, 6.1%) and 15 (0.7%) died with pulmonary
hemorrhage. A case-control study found that case-patients were more likely than controls to
have ever walked in creeks (matched odds ratio [MOR], 15.0; 95% confidence interval [CI],
1.7–132.3), have household rodents (MOR, 10.4; 95% CI, 1.1–97.1), or own dogs with titers
≥400 to Leptospira species (MOR, 23.4; 95% CI, 3.6–`). Twenty-six of 51 case-patients had
serologic or postmortem evidence of acute leptospirosis. Leptospira species were isolated from
case-patients and potential animal reservoirs. This leptospirosis epidemic likely resulted from
exposure to flood waters contaminated by urine from infected animals, particularly dogs.
Leptospirosis should be included in the differential diagnosis for nonmalarial febrile illness,
particularly during periods of flooding or when pulmonary hemorrhage occurs.

Leptospirosis is a zoonosis of worldwide distribution with
many wild and domestic animal reservoirs [1]. Human infection
typically results from exposure to infected animal urine, by
either direct contact or indirect exposure through water or soil
[2]. The early clinical presentation is often nonspecific, with
fever, headache, chills, myalgia, and abdominal pain. Two classic forms of leptospirosis have been described: the anicteric
(most common and mildest) and the icteric (Weil’s syndrome),
which causes severe renal, hepatic, and vascular dysfunction

[3]. Mild pulmonary involvement has been reported in
20%–70% of leptospirosis patients but is often overshadowed
by other manifestations [4]. Except for case reports from Brazil, leptospirosis with severe pulmonary involvement has not
been reported previously in the Western Hemisphere [5, 6]. Leptospirosis epidemics with pulmonary hemorrhage and few or
no jaundiced patients have been reported in Korea and China
[7, 8].
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Background

During October and November 1995, two health centers in the
neighboring rural jurisdictions of Achuapa and El Sauce in western
Nicaragua (total population, 37,030) reported an increased number
of patients with an illness characterized by fever, headache, chills,
and musculoskeletal pain; some died with hemorrhagic manifestations and shock [9]. No jaundice or renal manifestations were
reported. These reports immediately followed a series of tropical
storms, with rainfall reaching 5000 mm by October 1995, compared
with an annual average of 1300 mm during 1992–1994. During

1458

Trevejo et al.

9–29 October 1995, 100 patients from Achuapa were diagnosed
with “hemorrhagic fever” and hospitalized; males and females were
equally affected, and the majority were between 5 and 14 years of
age.
In October 1995, the Nicaraguan Ministry of Health (MOH)
initiated epidemiologic and laboratory investigations in collaboration with the United States Centers for Disease Control and
Prevention (CDC). The study objectives were the following: to
identify and characterize the etiologic agent through laboratory
studies, to describe the epidemic and clinical illness, and to identify
possible risk factors and prevention strategies. The study site consisted of the neighboring jurisdictions of Achuapa and El Sauce,
including their towns and associated outlying areas (5107 km2).

Descriptive Epidemiology

The cumulative incidence of nonmalarial febrile illness in the
study site for October and November 1995 was estimated by using
a register of patient visits to the two health centers. National hospital surveillance data collected by the Nicaraguan MOH for fatal
hemorrhagic fever cases occurring in October and November 1995
were used to estimate the case-fatality rate for the study site.

Case-Control Study (CCS)

Study site health centers’ medical records from October 1995
were reviewed to identify potential case-patients for enrollment in
the CCS. Case-patients were defined as having the following: fever
with onset during October 1995; headache, musculoskeletal pain,
or chills; abdominal pain, respiratory distress, hemorrhagic manifestations, or hypotension; negative results for malaria by blood
smear; and an illness severe enough to require hospitalization.
Case-patients who died with pulmonary hemorrhage in October or
November 1995 were interviewed by proxy. A standardized questionnaire collected information on daily activities and travel during
October 1995, food and water sources, environment, and preexisting medical conditions. The illness history of case-patients and
other family members was also determined.
One control subject was randomly selected for each case-patient
from the same town or outlying area and matched by age group
(0–4 years, 5–14 years, and ≥15 years). For the selection of controls
from towns, town maps were consulted, and one block was randomly selected for each case-patient, from which interviewers were
instructed to randomly select one household. For the selection of
controls from outlying areas, a line listing of all persons by household in the district with the highest incidence was consulted, and
one household was randomly selected for each case-patient. For
controls from towns and outlying areas, if an appropriate agematched control was unavailable at a household, the next house
to the right or the next household on the list was selected, respectively. Potential controls with a history of fever during the month
of October were excluded.

Specimens Collected

Non-CCS specimens. The Nicaraguan MOH initially submitted 53 serum specimens and 4 postmortem tissue specimens from
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patients with outbreak-associated illness to CDC to rule out dengue
and other infectious agents associated with febrile hemorrhagic
illness. Entomologic surveys of the study site were conducted by
CDC and the Nicaraguan MOH to identify potential vectors of
mosquitoborne illnesses. During the field investigation, all available postmortem tissues from patients diagnosed with fever and
hemorrhage were obtained for pathologic and immunohistochemical evaluation at CDC.
Active surveillance specimens. From 14 through 30 November
1995, active surveillance was conducted at the two heath centers
and the regional referral hospital by requesting health care workers
at these sites to collect whole blood and urine for culture from
patients presenting with febrile illnesses not diagnosed as malaria
(nonmalarial febrile illnesses). An investigator would visit each site
at least once daily to retrieve collected specimens and to consult
with health care workers about which patients should provide specimens for culture.
CCS specimens. For the CCS, acute-phase serum specimens
were collected from case-patients by the MOH; control and convalescent-phase case-patient serum specimens were collected during
CCS interviews conducted from 14 through 22 November 1995.
Serum specimens were collected from all available household contacts of case-patients and all available domestic animals at CCS
households, regardless of illness history. In addition, febrile casepatients and household members who had not received antibiotics
were asked to provide whole blood and urine for culture. Whole
blood and urine for culture were obtained at CCS households from
domestic animals that had been ill during October 1995. Rodents
were trapped at CCS households and surrounding community sites,
serum specimens were collected, and kidneys were harvested for
culture and fluorescent antibody (FA) testing.
In December 1995, a follow-up survey was conducted of dogs
from households of patients identified through the CCS and active
surveillance to collect urine for culture, regardless of the dogs’
illness histories.

Laboratory Studies

Mosquitoes were pooled, triturated in BA-1 medium, and tested
for viruses by Vero cell plaque assay by a double agar overlay
system. Immunohistochemical and silver staining for Leptospira
species were done on postmortem tissue specimens [10].
The microscopic agglutination test (MAT) was used to determine
antibody titers to pathogenic Leptospira species [11]. Human and
animal serum specimens were tested against multiple serovars at
CDC and the Agricultural Research Service, US Department of
Agriculture (USDA), respectively. Inclusion of an antigen panel of
local isolates is recommended but was unavailable for this investigation [12].
FA testing was used to detect Leptospira antigen in rodent kidney
specimens [13].
Whole blood and urine specimens from humans and domestic
animals and rodent kidney tissues were cultured for Leptospira
species in polysorbate liquid medium (Introgen, Purchase, NY),
supplemented with 1.5% agar (Difco Laboratories, Detroit) and
neomycin (10 mg/mL) [14]. Cultures were shipped at room temperature to CDC, where they were incubated at 307C for a minimum of 3 months. Cultures were inspected by darkfield micros-

JID 1998;178 (November)

Leptospirosis with Pulmonary Hemorrhage

Figure 1. Nonmalarial febrile illnesses, Achuapa and El Sauce, Nicaragua, 1 October to 30 November 1995 (n 5 2259).

copy on arrival and weekly thereafter. Identification of Leptospira
isolates was done by CDC and USDA by use of serogrouping,
restriction endonuclease digestion, polymerase chain reaction,
restriction fragment length polymorphism, and 16s rRNA
sequencing.
The following laboratory case definitions were used for human
leptospirosis: confirmed, Leptospira species isolated from whole
blood or urine, ≥4-fold rise in titer, or demonstration of Leptospira
species in postmortem tissue by immunohistochemistry (IHC);
probable, a titer ≥400 to one or more serovars; and seronegative,
a titer !400 to all serovars. The following laboratory case definitions were used for leptospirosis in animals: confirmed, Leptospira
species isolated from whole blood or kidney tissue, or kidney tissue
positive for Leptospira species by FA; probable, a titer ≥400 to one
or more serovars; and seronegative, a titer !400 to all serovars.

Statistical Analysis

For the CCS, Epi Info 6.02 (CDC, Atlanta) was used to determine descriptive statistics and x2 analyses, including univariate
matched analyses. Variables identified as potential risk factors
(P ≤ .20) were analyzed by conditional logistic regression if they
were biologically plausible or had been suggested as important risk
factors in previous studies. Conditional logistic regression was done
with LogXact 1.3 (Cytel Software, Cambridge, MA) to obtain exact
and asymptotic estimates of the matched odds ratios (MOR) and
95% confidence intervals (CI); all variables were analyzed as dichotomous variables. For conditional logistic regression, variables
with associated P ≤ .05 when adjusted for sex were considered to
be significant.
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icantly higher (P ! .05) than the rates for the other age groups
(figure 2).
CCS.
The CCS questionnaire was administered to 51
(85.0%) of 61 eligible case-patients (or their proxy) and 51
matched controls. This included 25 (80.6%) of 31 recovered
case-patients from towns, all 15 (100.0%) recovered casepatients from the outlying areas, and (by proxy) 11 (73.3%) of
15 patients who died.
The case-patient group had a significantly higher percentage
of males (54.9%) than did the control group (31.4%) (P ! .05)
and had a slightly lower mean age (14.9 vs. 17.7 years). Signs
and symptoms reported by case-patients are listed in table 1.
A matched, univariate analysis found that case-patients were
significantly more likely than controls to have reported walking through creeks or swimming in rivers; on the other hand,
having rodents in household food storage areas, walking
through mud, or living in homes with dirt floors were not significantly associated with illness (table 2). Conditional logistic
regression, adjusting for sex, found that case-patients were significantly more likely than controls to have reported walking
through creeks or to have rodents in household food storage
areas; living in homes with dirt floors, walking through mud,
or swimming in rivers were not significantly associated with
illness (table 2).
Exact estimates of the MOR and 95% CI found that casepatients were significantly more likely than controls to own
seropositive dogs, but not more likely to own seropositive pigs
or cows, or to have rodents with laboratory evidence of leptospirosis on their property (table 3).
Laboratory studies.
Dengue virus, New World arenaviruses, lymphocytic choriomeningitis virus, bunyaviruses, filoviruses, flaviviruses, alphaviruses, spotted fever and typhusgroup rickettsiae, Ehrlichia chaffeensis, and Coxiella burnetii
were ruled out by serologic testing and polymerase chain reaction of serum specimens from the 53 patients with outbreakassociated illness and IHC studies of postmortem tissue specimens from the 4 patients with fever and pulmonary
hemorrhage [9]. No Aedes aegypti mosquitoes (the major dengue virus vector) were collected by entomologic surveys, and

Results
Descriptive epidemiology. During October and November
1995, 2259 patients were evaluated for nonmalarial febrile illnesses at the two study site clinics (figure 1). The estimated
cumulative incidence of nonmalarial febrile illness was 2259/
37,030 (6.1%), with males and females equally affected. The
estimated minimum case-fatality rate from pulmonary hemorrhage was 15/2259 (0.7%). The age-specific incidence for El
Sauce patients between the ages of 1 and 14 years was signif-

Figure 2. Age-specific incidence of nonmalarial febrile illnesses, El
Sauce, Nicaragua, 1 October to 30 November 1995.
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Table 1. Case-control study: reported symptoms or signs among
case-patients (n 5 51).
Symptom or sign

No. of case-patients affected (%)

Headache
Chills
Musculoskeletal pain
Vomiting
Dyspnea
a
Hemorrhage

46
45
41
35
31
20

(90)
(88)
(80)
(69)
(61)
(39)

a

Includes pulmonary hemorrhage in fatal cases (11), and among recovered
case-patients, hemoptysis (4), gingival and/or vaginal bleeding (2), epistaxis (1),
ecchymosis (1), and hematuria (1).

no viruses were isolated from the other mosquito species
cultured.
Leptospira species were initially identified by IHC and silver
staining in postmortem tissue specimens from the 4 patients
with fever and pulmonary hemorrhage [9]. Postmortem tissue
specimens were eventually obtained from 14 hemorrhagic fever
patients; 13 were positive for Leptospira species by IHC, and
5 of the 13 were enrolled in the CCS. Subsequent serologic
testing of the 53 outbreak-associated patients revealed titers
≥400 to one or more Leptospira serovars among 23 (43.4%).
Laboratory specimens were available from 39 (76.5%) of 51
case-patients from the CCS: serum specimens from 34 (17
paired and 17 single) and postmortem tissue specimens from
5. The mean collection time after onset was 7 days for acutephase serum specimens (range, 1–17) and 28 days for convalescent-phase serum specimens (range, 17–40). Fourteen
(27.5%) case-patients were laboratory-confirmed for leptospirosis, 12 (23.5%) were probable, and 13 (25.5%) were
seronegative.
Of serum specimens obtained from 47 (92.2%) of 51 controls,
36 (70.6%) were seronegative, and 11 (21.6%) had titers ≥400
to one or more Leptospira serovars. Serovars detected among
case-patients and controls are listed in table 4.
Of 200 household contacts of case-patients, 72 (36%) had
titers ≥400 to one or more Leptospira serovars. Household contacts were not significantly more likely than controls to have
titers ≥400 to Leptospira species (OR, 1.8; 95% CI, 0.8–4.1). A
history of febrile illness during October 1995 was reported by
67 (33.5%) household contacts but was not associated with
having a titer ≥400 to Leptospira species (OR, 1.2; 95% CI,
0.6–2.3).
Of 199 domestic animals from CCS households, 39 (56.5%)
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of 69 pigs, 29 (44.6%) of 65 dogs, 4 (33.3%) of 12 horses, and
16 (30.2%) of 53 cows had titers ≥400 to one or more Leptospira
serovars (table 4).
Serum or kidney specimens, or both, were collected from 190
rodents (134 mice [Mus musculus] and 56 rats [Rattus rattus]):
69 (36.3%) from CCS households and 121 (63.9%) from other
sites in the community. Three (1.8%) of 165 available rodent
serum specimens had titers ≥400 to one or more Leptospira
serovars (table 4). Of 59 available rodent serum specimens from
CCS households, 1 (3.0%) of 33 from case-patient households
and 1 (3.8%) of 26 from control households had titers ≥400 to
one or more Leptospira serovars.
Kidney specimens were available from 185 (97.4%) rodents
for FA testing; 81 (43.8%) were positive for Leptospira species,
including 67 (51.1%) of 131 from mice and 14 (25.9%) of 54
from rats. Mice were significantly more likely to have kidney
tissue positive for Leptospira species by FA testing than were
rats (OR, 3.0; 95% CI, 1.4–6.4). Of 67 available rodent kidney
specimens from CCS households, 16 (38.1%) of 42 from casepatient households and 12 (48%) of 25 from control households
were positive by FA.
Of whole blood and urine specimens from 4 CCS household
animals that had been ill during October 1995, Leptospira interrogans serovar pomona type kennewicki was isolated from
the urine of a pig. A case-patient household mouse had kidney
tissue positive by culture for L. interrogans serovar canicola
and positive for Leptospira species by FA and a serum specimen
with a titer of 200 to serovar canicola. The follow-up survey
in December 1995 collected urine from 10 dogs from households
of patients identified through the CCS and active surveillance,
of which 6 (60%) were culture-positive for L. interrogans serovar
canicola.
Through active surveillance, L. interrogans isolates were obtained from blood of 3 acutely ill patients and from urine of 1
convalescent patient: 2 serovar canicola isolates and 2 serogroup Pyrogenes isolates for which no serovar classification
currently exists.

Discussion
A large epidemic of human leptospirosis resulted in high
morbidity and mortality in Nicaragua in October and Novem-

Table 2. Potential risk factors among case-control study participants with associated matched odds ratios
(MORs) and 95% confidence intervals (95% CIs) (n 5 51 matched pairs).
Risk factor
Walking in creeks
Rodents in food storage areas
Dirt floor in home
Walking in mud
Swimming in river/creek
a

Adjusted for sex.

Exposed case-patients
(n 5 51)

Exposed controls
(n 5 51)

30
14
43
38
23

18
7
37
32
13

Univariate MOR
(95% CI)
13.0
4.5
3.0
4.0
3.0

(2.0–552.5)
(0.9–42.8)
(0.8–17.2)
(0.8–38.7)
(1.04–10.6)

a

Multivariate MOR
(95% CI)
15.0
10.4
3.4
3.2
2.5

(1.7–132.3)
(1.1–97.1)
(0.8–13.6)
(0.7–15.5)
(0.9–7.3)
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Table 3. Animals from case-patient and control households with laboratory evidence of leptospirosis, with associated matched odds ratios
(MORs) and 95% confidence intervals (95% CIs).

Canine
Bovine
Porcine
Equine
Rodents

Case-patients

Controls

Multivariate MOR (95% CI)

21/28
9/28
21/40
2/6
16/43

8/37
7/25
18/29
2/6
12/26

23.4 (3.6–`)
1.5 (0.1–14.4)
0.5 (0.1–4.1)
Insufficient data
0.9 (0.2–4.0)

NOTE. Data include results from serology, fluorescent antibody testing (rodents only), and culture and are no. positive/total tested.

ber 1995. The most likely explanation for this epidemic was
increased exposure to flood waters that had become contaminated by urine from animals infected with Leptospira species
[15]. The recovery of multiple serovars from humans and animals during this epidemic implies involvement of more then
one serovar in the epidemic and is consistent with flood contamination of groundwater and the epidemiologic association
between illness and creek exposure. Temporal associations
between heavy rainfall and human leptospirosis have been reported in Brazil, Puerto Rico, and Barbados [5, 16, 17]. A recent
outbreak found an association between illness and ingesting or
being submersed in river water during a rafting trip in Costa
Rica early in the rainy season [18].
A unique feature of this investigation is the combined, systematic sampling of humans and animals in the study site for
epidemiologic and laboratory studies. A 1962 study of the
epidemiology of leptospirosis in Nicaraguan domestic and wild
animals recovered 9 L. interrogans serovar canicola isolates
from mammals trapped in the western region but did not
examine for any associations with human leptospirosis [19].
Previous leptospirosis outbreaks have included sampling of potential animal reservoirs, but not in the context of a CCS [7,
8, 20–22]. The approach of the current study allowed identification of potential animal reservoirs and assessment of epidemiologic risk associated with animal contact.
The selection of recently or currently symptomatic domestic
animals from CCS households for culture was a limitation of
the CCS, since leptospirosis in animals is often asymptomatic
and Leptospira species can be shed in the urine for prolonged
periods [15, 23]. However, serology conducted for all available
domestic animals from CCS households, regardless of illness
history, found a high seroprevalence (56.5%). In addition, urine
from 6 (60%) of 10 dogs sampled during the follow-up survey
was culture-positive for L. interrogans serovar canicola.
The high infection rate among dogs, the predominance of
serovar canicola isolates, the high seroprevalence to serovar
canicola among case-patients, and the epidemiologic risk associated with ownership of dogs with titers ≥400 to Leptospira
species suggest that urine shedding by infected dogs played a
major role in amplifying the level of environmental contamination near households (peridomestic amplification) during the
epidemic. It is possible that disease transmission resulted from
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direct or indirect exposure to urine from infected dogs, a common-source exposure (i.e., creeks or rivers) for dogs and humans, or a combination of both. Given the propensity of young
children for outdoor activities and animal contact, exposure to
contaminated water or infected dogs, or both, would also account for the high incidence among children and the equal
distribution among male and female case-patients. Flooding
would presumably result in contamination of water sources by
multiple animal species, but of domestic animal exposures, only
ownership of seropositive dogs was found to be associated with
illness. In a retrospective CCS, it is only possible to hypothesize
about potential scenarios for disease transmission, since the
timing of each exposure in relation to the development of disease cannot be distinguished. This study raises questions about
the role of dogs and different environmental exposures that need
to be explored in future studies.
Seroprevalence to Leptospira serovars was much higher
among domestic animals (56.5%) than among rodents (1.8%).
A high rate of carriage among rodents was shown by the high
percentage of FA results that were positive for Leptospira species (43.5%). The low seroprevalence among rodents suggests
a maintenance host infection with a resultant poor immunologic
response or possible carriage of new or previously unrecognized
serovars or serovars not represented on the MAT panel [24,
25]. There was a slight epidemiologic risk of illness associated
with having rodents in household food storage areas after adjusting for sex in the multivariate model. The doubling of the
odds ratio for having rodents in household food storage areas
after adjusting for sex is due to the higher proportion of men
in the case-patient group. Men reported seeing rodents in household food storage areas much less frequently than women, likely
because they tended to work outside the home and not be
involved with food preparation. However, the role of rodents
as reservoirs in this epidemic remains unclear, since only 1 rodent isolate was recovered.
Some case-patients may have been seronegative because of
timing of specimen collection, the antigen panel used for the
MAT, or case-patient misclassification. For instance, serum
specimens may have been collected before seroconversion for
some case-patients. It is estimated that up to 10% of patients
may not seroconvert within 30 days of clinical onset, a cutoff
that some case-patients fell short of in this study [14]. It is
possible that inclusion of an antigen panel of local isolates,
which was unavailable for this investigation, may have increased the sensitivity of the MAT. Misclassification of casepatients could have occurred if other illnesses, such as malaria
or dengue, were responsible for the observed clinical symptoms.
For instance, someone with a blood smear that was falsely
negative for malaria agents, but who met the clinical criteria
of the CCS, would have been misclassified as a case-patient.
Dengue as a cause of misclassification bias is less likely, since
there was no evidence of dengue in the study site.
Controls with titers ≥400 to Leptospira species may have been
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Table 4. Microscopic agglutination test-positive specimens by Leptospira serovar.
Serovar (strain)

Case-patients

Controls

Canine

Porcine

Bovine

Equine

Rodent

alexi
australis
autumnalis
ballum (Mus 127)
ballum (S102)
bratislava
canicola (Hond-Utrecht IV)
celledoni
copenhageni
grippotyphosa
hardjobovis
icterohaemorrhagiae
mankarso
pomona (Pomona)
pomona type kennewicki
pyrogenes
shermani
wolffi

4/33 (12.1)
1/32 (3.1)
3/33 (9.1)
12/33 (36.4)
ND
5/33 (15.2)
18/33 (54.5)
1/30 (3.3)
7/32 (21.9)
0/33
ND
6/33 (18.2)
11/33 (33.3)
2/33 (6.1)
ND
12/33 (36.4)
ND
1/33 (3.0)

0/47
2/47 (4.3)
2/47 (4.3)
2/47 (4.3)
ND
6/47 (12.8)
7/47 (14.9)
0/47
1/41 (2.4)
0/47
ND
4/47 (8.5)
0/47
1/47 (2.1)
ND
5/47 (10.6)
ND
1/47 (2.1)

ND
1/65 (1.5)
ND
ND
20/65 (30.8)
8/65 (12.3)
22/65 (33.8)
ND
ND
ND
3/65 (4.6)
4/65 (6.2)
ND
ND
1/65 (1.5)
12/65 (18.5)
4/55 (7.3)
0/64

1/69 (1.4)
0/69
1/69 (1.4)
ND
27/69 (39.1)
6/69 (8.7)
24/69 (34.8)
ND
ND
1/63 (1.6)
0/69
24/69 (34.8)
ND
ND
5/69 (7.2)
5/69 (7.2)
18/69 (26.1)
ND

ND
0/53
ND
ND
8/53 (15.1)
3/53 (5.7)
7/53 (13.2)
ND
ND
ND
1/53 (1.9)
2/53 (3.8)
ND
ND
3/53 (5.7)
3/53 (5.7)
1/43 (2.3)
4/52 (7.5)

ND
1/12 (8.3)
ND
ND
1/12 (8.3)
2/12 (16.7)
0/12
ND
ND
0/12
0/12
2/12 (16.7)
ND
ND
1/12 (8.3)
2/12 (16.7)
1/2 (50.0)
1/12 (8.3)

ND
0/165
ND
ND
2/165 (1.2)
0/165
2/165 (1.2)
ND
ND
ND
0/165
3/165 (1.8)
ND
ND
0/165
0/165
3/165 (1.8)
0/165

NOTE. Data are no. positive/total tested (%). ND 5 not done. No reactivity was demonstrated to serovars bataviae, borincana, cynopteri, georgia, and tarassovi
in human serum specimens; to serovar djasiman in human or rodent serum specimens; or to serovar javanica in human, canine, bovine, or equine serum specimens.
Other species were not tested for these serovars.

misclassified as a result of subclinical infection with Leptospira
species. It is also possible that some of these controls had serologic evidence of a previous infection with Leptospira species.
Laboratory criteria were not used in the CCS to exclude casepatients or controls because of the limitations of laboratory
testing discussed above and the lack of availability of clinical
specimens for some CCS participants who otherwise met the
clinical criteria. However, the results of a separate analysis,
which included only case-patients with laboratory evidence of
infection and seronegative controls, were similar to those obtained when only the clinical criteria were used.
Leptospirosis was first diagnosed in patients who had died
with pulmonary hemorrhage. In addition to the 15 reports from
the study site, 33 hemorrhagic fever deaths were reported from
other areas of Nicaragua. Possible reasons for the high observed
number of cases with pulmonary hemorrhage are that the magnitude of the epidemic was such that this number of cases would
not be unexpected or that there was a new or previously unrecognized serovar more likely to cause pulmonary hemorrhage. The former explanation seems more likely, given the
estimated cumulative incidence (6.1%) in the study site during
October and November 1995. Since clinical specimens were
unavailable for culture from the 13 patients who were confirmed
by IHC, the possibility of a new or previously unrecognized
serovar associated with pulmonary hemorrhage cannot be ruled
out. Efforts are currently underway to identify Leptospira species serovars in postmortem tissue sections by polymerase chain
reaction.
The absence of jaundice is inconsistent with the classic description of the severe form of leptospirosis (Weil’s syndrome)
[1–3, 26]. The perception persists that jaundice characterizes
severe leptospirosis, despite reports of leptospirosis with pul-

monary hemorrhage from Korea, China, and Brazil in which
few or no patients developed jaundice [5–8]. In these epidemics, fatality rates ranging from 2.4% to 5% were reported for
patients with hemoptysis, respiratory distress, and pulmonary
hemorrhage. Although no single serovar was implicated in these
epidemics, serovar icterohaemorrhagiae isolates were recovered
from the Chinese epidemic, and 1 serovar lai isolate was recovered from the Korean epidemic.
Several measures could be taken to prevent and control morbidity and mortality in future epidemics. Providing community
education to residents in at-risk areas on the need for exclusion
of domestic animals and rodents from households and food
and water sources, removal of potential rodent harborage, institution of appropriate food storage practices, and avoidance
of contact with potentially contaminated water can reduce the
risk of exposure. Increased awareness of leptospirosis and its
respiratory manifestations among physicians in at-risk areas
should increase the likelihood that patients will be diagnosed
and treated appropriately. The early detection of leptospirosis
would be enhanced by the local availability of rapid, easily
performed, sensitive diagnostic tests [27, 28]. Inclusion of leptospirosis in the differential diagnosis for febrile illness in areas
at high risk for malaria and dengue, particularly during periods
of flooding, is essential. Prompt administration of penicillin,
based on clinical suspicion of leptospirosis, could be lifesaving,
or at least reduce the severity of illness, in circumstances when
rapid laboratory diagnostics are not available. While antibiotic
prophylaxis is indicated in certain situations, such as military
training or travel in areas in which leptospirosis is highly endemic, an evaluation of the effectiveness, feasibility, and safety
of community-wide prophylaxis in the face of a leptospirosis
epidemic is still needed.
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